Cargando…
Duchenne Muscular Dystrophy Newborn Screening, a Case Study for Examining Ethical and Legal Issues for Pilots for Emerging Disorders: Considerations and Recommendations
Duchenne muscular dystrophy (DMD/Duchenne) is one of the ten most severe and common pediatric genetic diseases and affects an estimated 1 in every 5000 male births. While Duchenne is a 100% fatal disease, the clinical community has demonstrated that immediate identification and early clinical interv...
Autores principales: | Lloyd-Puryear, Michele A., Crawford, Thomas O., Brower, Amy, Stephenson, Kristin, Trotter, Tracy, Goldman, Edward, Goldenberg, Aaron, Howell, R. Rodney, Kennedy, Annie, Watson, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548894/ https://www.ncbi.nlm.nih.gov/pubmed/33072932 http://dx.doi.org/10.3390/ijns4010006 |
Ejemplares similares
-
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022) -
A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy
por: Al-Zaidy, Samiah A., et al.
Publicado: (2017) -
Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot
por: Hartnett, Michael J., et al.
Publicado: (2022) -
Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study
por: Tavakoli, Norma P., et al.
Publicado: (2023) -
Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP(®) Neonatal Creatine Kinase-MM Kit in a US and Danish Population
por: Timonen, Anne, et al.
Publicado: (2019)